Inspection Report

Ararat Nursing Facility: Medication Errors, Safety Gaps CA

October 2, 2025

Mission Hills, CA

278 views

MISSION HILLS, CA - Federal inspectors found serious medication management violations at Ararat Nursing Facility during an August 2024 inspection, including failures to properly monitor psychotropic medications and medication administration errors that placed residents at risk for medical complications.

Psychotropic Medication Monitoring Failures

The most significant violation involved the facility's failure to properly monitor and reduce psychotropic medications as required by federal regulations. Inspectors found that Resident 79, who had been prescribed Trazodone 75 mg for depression and insomnia since June 2023, continued receiving the medication despite showing no symptoms that warranted its continued use.

According to the inspection report, the resident's July 2024 medication records showed no documented episodes of insomnia throughout the entire month. The resident's psychiatric evaluation in July indicated stable behavior with only "infrequent behaviors" reported by staff. Despite these positive signs, the facility failed to attempt a gradual dose reduction (GDR) as required by federal nursing home regulations.

Federal regulations mandate that nursing homes attempt to reduce psychotropic medication doses in two separate quarters within the first year of treatment, with at least one month between attempts. The consultant pharmacist had specifically requested in July 2024 that the attending physician assess whether a dose reduction was appropriate, noting that federal regulations required this evaluation. However, the facility failed to provide adequate clinical documentation justifying why the medication should continue at its current dose.

The Director of Nursing acknowledged during the inspection that there was no clinical rationale found for continuing the Trazodone at the prescribed dose. The DON stated that "based on Resident 79 not exhibiting behaviors of insomnia for July 2024, there should have been an attempt for a GDR and/or documentation in the psychiatry note indicating a clinical rationale for continuing the Trazodone."

Medical Significance of Psychotropic Medication Oversight

Proper monitoring of psychotropic medications in nursing homes is essential for resident safety and well-being. Trazodone, while commonly prescribed for depression and insomnia, carries risks including sedation, dizziness, and increased fall risk - particularly concerning for elderly nursing home residents. When residents no longer exhibit the symptoms for which these medications were prescribed, continuing unnecessary psychotropic drugs can expose them to serious side effects without therapeutic benefit.

The failure to attempt dose reductions when clinically appropriate violates the principle of using the lowest effective dose to minimize adverse effects. Elderly residents are particularly vulnerable to medication side effects, and unnecessary psychotropic medications can contribute to cognitive impairment, increased fall risk, and decreased quality of life.

Industry standards require that nursing homes regularly evaluate whether residents still need psychotropic medications and attempt reductions when residents' conditions improve or stabilize. This approach helps ensure residents receive optimal treatment while avoiding unnecessary medication exposure.

Unsafe Insulin Administration Practices

Inspectors also identified significant medication errors in insulin administration that affected multiple residents. The facility failed to properly rotate injection sites for subcutaneous insulin administration, a basic safety requirement that prevents serious medical complications.

The inspection found that nursing staff were not rotating insulin injection sites for two residents requiring insulin therapy. Proper site rotation involves systematically changing injection locations to prevent tissue damage and ensure consistent medication absorption. When insulin is repeatedly administered in the same area, it can cause lipodystrophy - an abnormal distribution of fat tissue - and cutaneous amyloidosis, where abnormal proteins accumulate in the skin.

These complications are not merely cosmetic concerns. Lipodystrophy can significantly affect insulin absorption, leading to unpredictable blood sugar control. Poor glycemic control in diabetic nursing home residents can result in serious complications including diabetic ketoacidosis, hypoglycemic episodes, and increased risk of infections.

Industry Standards for Insulin Administration

Proper insulin injection technique is a fundamental nursing skill that requires systematic site rotation to maintain tissue integrity and ensure consistent medication absorption. The American Diabetes Association and other medical organizations provide clear guidelines on injection site rotation, typically recommending rotation within the same body region (such as different areas of the abdomen) before moving to other sites.

Nursing homes are expected to train staff on proper injection techniques and maintain systems to track injection sites for each resident. This basic safety measure prevents predictable complications and ensures that residents receive the full therapeutic benefit of their insulin therapy.

The facility's failure to implement proper injection site rotation represents a significant departure from established nursing standards and places residents at unnecessary risk for preventable complications.

Regulatory Context and Compliance Requirements

The violations occurred despite the facility having written policies addressing both psychotropic medication management and behavioral interventions. The facility's Psychotherapeutic Drug Management policy, updated in May 2024, specifically outlined requirements for gradual dose reduction attempts and proper documentation of clinical rationales for continuing medications.

The policy stated that efforts to reduce or discontinue psychotropic medications should be "ongoing, as appropriate, for the clinical situation" and that physicians must document their rationale when no action is taken in response to pharmacist recommendations. The policy also emphasized goals of achieving the lowest effective dose and minimizing exposure to adverse consequences.

However, the inspection revealed a significant gap between written policies and actual practice. The facility's failure to follow its own established procedures demonstrates systemic issues in medication management oversight and clinical decision-making processes.

Additional Issues Identified

The inspection also documented the facility's inadequate response to consultant pharmacist recommendations. When the pharmacist specifically requested evaluation for dose reduction in July 2024, the facility failed to provide any documented physician response, despite policy requirements for timely responses to pharmacist concerns.

The facility's Behavioral Management policy, dating to 2017, required appropriate assessment of behavioral symptoms and implementation of interventions before using psychotherapeutic medications. The policy emphasized that pharmacological interventions should only be used when non-pharmacological approaches are ineffective or clinically indicated.

The inspection findings suggest broader systemic issues in the facility's medication management processes, including inadequate physician oversight, insufficient nursing staff training on injection techniques, and poor communication between clinical disciplines. These deficiencies collectively compromised the quality of care provided to residents requiring complex medication management.

The violations identified during this inspection highlight the critical importance of robust medication management systems in nursing homes, where residents often require multiple medications and are particularly vulnerable to adverse effects from inappropriate prescribing or administration errors.

Full Inspection Report

The details above represent a summary of key findings. View the complete inspection report for Ararat Nursing Facility from 2024-08-09 including all violations, facility responses, and corrective action plans.

Additional Resources

Editorial Standards

Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).

Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.

Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.

Last verified: June 22, 2026 · Our methodology

Quick Answer

Ararat Nursing Facility in MISSION HILLS, CA was cited for violations during a health inspection on August 9, 2024.

According to the inspection report, the resident's July 2024 medication records showed **no documented episodes of insomnia throughout the entire month**.

Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.

Frequently Asked Questions

What happened at Ararat Nursing Facility?

According to the inspection report, the resident's July 2024 medication records showed **no documented episodes of insomnia throughout the entire month**.

How serious are these violations?

Violation severity varies from minor documentation issues to serious safety concerns. Review the inspection report for specific deficiency codes and scope. All violations must be corrected within required timeframes and are subject to follow-up verification inspections.

What should families do?

Families should: (1) Ask facility administration about specific corrective actions taken, (2) Request to see the follow-up inspection report verifying corrections, (3) Check if this represents a pattern by reviewing prior inspection reports, (4) Compare this facility's ratings with other nursing homes in MISSION HILLS, CA, (5) Report any new concerns directly to state authorities.

Where can I see the full inspection report?

The complete inspection report is available on Medicare.gov's Care Compare website (www.medicare.gov/care-compare). You can also request a copy directly from Ararat Nursing Facility or from the state Department of Health. The report includes specific deficiency codes, facility responses, and correction timelines. This facility's federal provider number is 555579.

Has this facility had violations before?

To check Ararat Nursing Facility's history, visit Medicare.gov's Care Compare and review their inspection history, quality ratings, and staffing levels. Look for patterns of repeated violations, especially in critical areas like abuse prevention, medication management, infection control, and resident safety.